Cintas vs Copart: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Cintas Corporation (CTAS)

Q3 202614 Jul – 7 Oct 2026

▲1▼1

Record Q1, dividend hike, but UniFirst deal faces FTC delay

Record Q1 results and raised guidance Cintas reported record fiscal Q1 revenue up about 11% to $3.01 billion and adjusted earnings per share up 15.8% to $1.39, then raised its full-year outlook and lifted its dividend 15.6%. Bank of America upgraded the stock.
Strong earnings and a dividend increase are direct positive drivers of the stock.
FTC scrutiny delays UniFirst acquisition The $5.5 billion UniFirst acquisition faced FTC scrutiny, and the odds of the deal closing fell to roughly 70% from 85%, threatening expected growth and cost savings. Closing is barred before December 11 absent earlier clearance.
Regulatory risk to a major acquisition is a key negative force on the stock.
Compliance certification lowers breakup risk Cintas and UniFirst later certified substantial compliance with the FTC's second request, which lowers the risk that the deal falls apart. However, the deal still cannot close before December 11 without earlier clearance.
This reduces uncertainty but does not remove the regulatory hurdle, so it is mixed.
President and CEO roles split Cintas split its President and CEO roles, a move aimed at improving efficiency. The operational payoff is uncertain, so the market impact is mixed.
A leadership change with unclear near-term effect is a mixed driver.

August 202614 Jul – 7 Oct 2026

▲1▼1

Record Q1, dividend hike, but UniFirst deal faces FTC delay

Record Q1 results and raised guidance Cintas reported record fiscal Q1 revenue up about 11% to $3.01 billion and adjusted earnings per share up 15.8% to $1.39, then raised its full-year outlook and lifted its dividend 15.6%. Bank of America upgraded the stock.
Strong earnings and a dividend increase are direct positive drivers of the stock.
FTC scrutiny delays UniFirst acquisition The $5.5 billion UniFirst acquisition faced FTC scrutiny, and the odds of the deal closing fell to roughly 70% from 85%, threatening expected growth and cost savings. Closing is barred before December 11 absent earlier clearance.
Regulatory risk to a major acquisition is a key negative force on the stock.
Compliance certification lowers breakup risk Cintas and UniFirst later certified substantial compliance with the FTC's second request, which lowers the risk that the deal falls apart. However, the deal still cannot close before December 11 without earlier clearance.
This reduces uncertainty but does not remove the regulatory hurdle, so it is mixed.
President and CEO roles split Cintas split its President and CEO roles, a move aimed at improving efficiency. The operational payoff is uncertain, so the market impact is mixed.
A leadership change with unclear near-term effect is a mixed driver.

Latest14 Jul – 7 Oct 2026

▲3

Cintas beats, raises guidance, and clears a key FTC hurdle

Record quarter and raised outlook Cintas reported fiscal first-quarter revenue up 11% to $3.01 billion and adjusted EPS of $1.39, then raised its fiscal 2027 revenue and EPS guidance. A growing, more profitable core business supports a higher stock price.
The latest earnings beat and guidance raise are the main new fundamental driver of CTAS shares.
UniFirst deal clears FTC compliance step Cintas and UniFirst certified they substantially complied with the FTC's second request and agreed not to close before Dec. 11 unless cleared sooner. This lowers the risk the $5.5 billion deal falls apart, supporting the stock.
Regulatory progress on the UniFirst acquisition is a major new event affecting CTAS's growth outlook.
Dividend raised 15.6% Cintas lifted its quarterly dividend 15.6% to $0.52 per share, payable September 15. A bigger payout signals confidence in cash flow and rewards shareholders, which tends to support the stock.
The dividend increase is a concrete new capital-return action for shareholders.
Leadership split puts focus on operations and capital Cintas separated the President and CEO roles, naming Jim Rozakis President and COO while Todd Schneider stays CEO. The change aims to sharpen efficiency and capital allocation, but the operational payoff is uncertain.
The leadership change is a new governance event that could affect how Cintas is run and valued.

15 Jul – 23 Sep 2026

▲3▼1

Cintas beats and raises guidance, but UniFirst deal faces FTC hurdle

Record Q1 results and raised fiscal 2027 outlook Cintas reported record first-quarter revenue of $3.01 billion, up 10.9%, and adjusted EPS of $1.39, up 15.8%. It raised full-year revenue and EPS guidance and lifted its dividend 15.6%. This shows the core business is strong and growing, which supports a higher stock price.
This is the most recent and concrete evidence of the company's strong operating performance, directly driving the stock up.
FTC scrutiny lowers odds of UniFirst acquisition Bernstein said the market-implied chance of the UniFirst deal closing fell to about 70% from 85% due to FTC civil investigative demands and a critical industry report. If the deal falls through, Cintas loses expected growth and cost savings, which pressures the stock.
This is a new regulatory development that creates uncertainty and weighs on the stock price.
Strong Q4 results and initial fiscal 2027 guidance In July, Cintas reported Q4 revenue up 8.9% to $2.91 billion and adjusted EPS of $1.29, beating estimates. It guided fiscal 2027 revenue to $12.10–$12.25 billion and EPS to $5.36–$5.50, showing confidence in continued growth.
This was the first signal of the company's strong momentum and set the stage for the subsequent stock gains.
Bank of America upgrade and analyst optimism Bank of America upgraded Cintas to buy in mid-July, helping shares gain 6.5% that day. Analyst upgrades can boost investor confidence and attract buyers, pushing the stock higher.
This is a new analyst action that contributed to the stock's rise during the period.

Copart Inc (CPRT)

Q3 202614 Jul – 5 Oct 2026

▼2▲1

Copart buys ACV, founder returns, but weak results and probes weigh

Copart's $1.9B cash purchase of ACV Auctions Copart agreed to buy ACV Auctions for $1.9 billion in cash, adding 800,000 yearly dealer vehicle sales and reducing reliance on its shrinking U.S. insurance business, where volume fell 8% in fiscal 2026. The deal should add to profit by fiscal 2028.
The largest strategic move of the quarter, reshaping Copart's business mix and growth outlook.
Founder Jay Adair returns as sole CEO Founder Jay Adair came back as sole CEO with backing from SVN Capital, while Copart holds $4.2 billion in cash and no debt. Leadership stability and a strong balance sheet support the ACV deal and future investment.
A major leadership change that restores founder-led direction and reassures investors about execution.
Weak Q4 profit and soft full-year growth Fourth-quarter profit fell 17.4%, earnings per share missed expectations, margins shrank, and full-year revenue grew just 0.4%. The weak results highlight pressure on Copart's core insurance auction business.
Directly shows deteriorating financial performance that weighs on the stock.
CEO exit triggers probes and analyst downgrade CEO Jeff Liaw's exit led to securities fraud investigations, a director sold 80,000 shares, and Barclays cut its price target to $25, citing declining insurance volumes. These events raise governance and demand concerns.
Adds legal and reputational risk while analyst caution reflects underlying business challenges.

August 202614 Jul – 5 Oct 2026

▼2▲1

Copart's CEO Exit, Weak Q4, and $1.9B ACV Deal Drive the Story

CEO exit triggers securities fraud investigations Jeff Liaw's June 29 exit as CEO sent the stock down 8%, and law firms Pomerantz and Bragar Eagel & Squire are now investigating possible securities fraud. Legal uncertainty and leadership upheaval weigh on the stock.
New investigations tied to the CEO departure are a fresh negative overhang on CPRT.
Director sells 80,000 shares Director Daniel Englander sold 80,000 shares for $2.2 million, cutting his holdings by 14%. Insider selling can signal executives see limited upside, and it adds to negative sentiment.
A fresh insider sale is a new negative signal for investors.
Founder Jay Adair returns as sole CEO SVN Capital backs Jay Adair, a founding member, returning as sole CEO for at least a decade. He says lost insurance volume was one account, not a broken franchise. Copart has $4.2B cash and no debt.
New leadership confidence and a strong balance sheet are a positive counterweight to the CEO exit.
$1.9B ACV deal adds dealer volume as insurance shrinks Copart will pay about $1.9B cash for ACV, adding 800,000 dealer vehicle sales a year. U.S. insurance volume fell 8% in fiscal 2026, so this diversifies away from a shrinking core. Breakeven at first, accretive by fiscal 2028.
The ACV acquisition is the biggest strategic move this period, reshaping Copart's growth path.

Latest14 Jul – 5 Oct 2026

▼2▲1

Copart's CEO Exit, Weak Q4, and $1.9B ACV Deal Drive the Story

CEO exit triggers securities fraud investigations Jeff Liaw's June 29 exit as CEO sent the stock down 8%, and law firms Pomerantz and Bragar Eagel & Squire are now investigating possible securities fraud. Legal uncertainty and leadership upheaval weigh on the stock.
New investigations tied to the CEO departure are a fresh negative overhang on CPRT.
Director sells 80,000 shares Director Daniel Englander sold 80,000 shares for $2.2 million, cutting his holdings by 14%. Insider selling can signal executives see limited upside, and it adds to negative sentiment.
A fresh insider sale is a new negative signal for investors.
Founder Jay Adair returns as sole CEO SVN Capital backs Jay Adair, a founding member, returning as sole CEO for at least a decade. He says lost insurance volume was one account, not a broken franchise. Copart has $4.2B cash and no debt.
New leadership confidence and a strong balance sheet are a positive counterweight to the CEO exit.
$1.9B ACV deal adds dealer volume as insurance shrinks Copart will pay about $1.9B cash for ACV, adding 800,000 dealer vehicle sales a year. U.S. insurance volume fell 8% in fiscal 2026, so this diversifies away from a shrinking core. Breakeven at first, accretive by fiscal 2028.
The ACV acquisition is the biggest strategic move this period, reshaping Copart's growth path.

September 202629 Aug – 11 Sep 2026

▲1▼1

Copart's $1.9B ACV Deal and Weak Q4 Profits Shape the Story

Copart to buy ACV Auctions for $1.9B Copart agreed to acquire digital auction platform ACV for $1.9 billion in cash, a 45% premium. The deal adds ACV's 800k annual vehicle sales and $10B merchandise value, expanding Copart's dealer auction reach. Funded from cash, it's expected to be accretive by fiscal 2028. Shares rose 7% on the news.
This is the biggest new event, directly explaining the stock's recent jump and future growth path.
Q4 profit falls 17.4% as margins shrink Copart's fiscal Q4 net income dropped 17.4% to $327.4 million, and earnings per share fell to $0.35 from $0.41. Gross profit declined 5.5%. Full-year revenue barely grew, up 0.4%. The weak profit shows the core business is under pressure, which weighs on the stock.
This is the key counterweight: despite the deal excitement, underlying profits are shrinking.
Q2 revenue beat but EPS missed; stock jumped 9.5% Copart's Q2 revenue of $1.15 billion beat estimates, but GAAP EPS of $0.35 missed the $0.38 consensus. Operating margin fell to 32% from 36.7%, and free cash flow margin dropped to 24.2%. Despite the miss, the stock jumped 9.5%, likely on the revenue beat and deal news.
This earnings report shows the mixed fundamental picture that investors are weighing alongside the acquisition.
Copart in talks to buy CCC Intelligent Solutions Copart is reportedly in talks to acquire CCC, a digital claims platform, competing with private equity firms. The deal would combine Copart's salvage auctions with CCC's software. But Barclays cut its price target to $25 with an Underweight rating, citing potential volume declines from insurance contract changes.
This potential acquisition adds another strategic move, but the analyst downgrade highlights risks.

29 Aug – 11 Sep 2026

▲1▼1

Copart's $1.9B ACV Deal and Weak Q4 Profits Shape the Story

Copart to buy ACV Auctions for $1.9B Copart agreed to acquire digital auction platform ACV for $1.9 billion in cash, a 45% premium. The deal adds ACV's 800k annual vehicle sales and $10B merchandise value, expanding Copart's dealer auction reach. Funded from cash, it's expected to be accretive by fiscal 2028. Shares rose 7% on the news.
This is the biggest new event, directly explaining the stock's recent jump and future growth path.
Q4 profit falls 17.4% as margins shrink Copart's fiscal Q4 net income dropped 17.4% to $327.4 million, and earnings per share fell to $0.35 from $0.41. Gross profit declined 5.5%. Full-year revenue barely grew, up 0.4%. The weak profit shows the core business is under pressure, which weighs on the stock.
This is the key counterweight: despite the deal excitement, underlying profits are shrinking.
Q2 revenue beat but EPS missed; stock jumped 9.5% Copart's Q2 revenue of $1.15 billion beat estimates, but GAAP EPS of $0.35 missed the $0.38 consensus. Operating margin fell to 32% from 36.7%, and free cash flow margin dropped to 24.2%. Despite the miss, the stock jumped 9.5%, likely on the revenue beat and deal news.
This earnings report shows the mixed fundamental picture that investors are weighing alongside the acquisition.
Copart in talks to buy CCC Intelligent Solutions Copart is reportedly in talks to acquire CCC, a digital claims platform, competing with private equity firms. The deal would combine Copart's salvage auctions with CCC's software. But Barclays cut its price target to $25 with an Underweight rating, citing potential volume declines from insurance contract changes.
This potential acquisition adds another strategic move, but the analyst downgrade highlights risks.